StockData
Evolent Health, Inc. logo

Evolent Health, Inc. (EVH) stock

EVHNYSEServices-Management ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3029% below fair value
$4.90+0.13 (+2.73%)

Close on Nov 13, 2026Market cap $553.99MP/E –Yield –

Evolent Health gross margin

Gross margin is gross profit as a percentage of revenue.

Evolent Health's gross margin for the twelve months ending Sep 30, 2026 was 15.0%. For fiscal 2025 it was 21.3%, against 14.4% the year before. The highest annual figure on record is 27.6% in fiscal 2021.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202521.3%+6.9
FY2024Dec 31, 202414.4%−9.1
FY2023Dec 31, 202323.4%+0.0
FY2022Dec 31, 202223.4%−4.2
FY2021Dec 31, 202127.6%+2.9
FY2020Dec 31, 202024.7%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 202612.2%−8.6
Q2 FY2026Jun 30, 202612.4%−10.2
Q1 FY2026Mar 31, 202616.9%−4.3
Q4 FY2025Dec 31, 202520.7%+9.0
Q3 FY2025Sep 30, 202520.8%+7.8
Q2 FY2025Jun 30, 202522.6%+6.1
Q1 FY2025Mar 31, 202521.2%+4.9
Q4 FY2024Dec 31, 202411.7%−6.6
Q3 FY2024Sep 30, 202413.0%−11.4
Q2 FY2024Jun 30, 202416.5%−8.5
Q1 FY2024Mar 31, 202416.3%−11.1
Q4 FY2023Dec 31, 202318.3%−3.4
Q3 FY2023Sep 30, 202324.3%−0.0
Q2 FY2023Jun 30, 202325.0%+3.0
Q1 FY2023Mar 31, 202327.4%+1.4
Q4 FY2022Dec 31, 202221.7%−12.1
Q3 FY2022Sep 30, 202224.4%−2.3
Q2 FY2022Jun 30, 202222.0%−0.5
Q1 FY2022Mar 31, 202226.0%–
Q4 FY2021Dec 31, 202133.8%–
Q3 FY2021Sep 30, 202126.7%–
Q2 FY2021Jun 30, 202122.5%–

More Evolent Health figures

See a number that looks wrong?